Healthcare provider profile · identity verified

Matthew Robert Thomas, MD

Family Practice · INDIAN LAND, SC · NPI 1720378136

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1059	299
Amlodipine Besylate	Amlodipine Besylate	595	171
Lisinopril	Lisinopril	443	121
Losartan Potassium	Losartan Potassium	393	105
Levothyroxine Sodium	Levothyroxine Sodium	312	88
Metformin Hcl	Metformin Hcl	303	81
Hydrochlorothiazide	Hydrochlorothiazide	292	78
Gabapentin	Gabapentin	263	72
Sertraline Hcl	Sertraline Hcl	243	72
Pravastatin Sodium	Pravastatin Sodium	240	68
Pantoprazole Sodium	Pantoprazole Sodium	232	64
Rosuvastatin Calcium	Rosuvastatin Calcium	230	63
Omeprazole	Omeprazole	211	59
Fluticasone Propionate	Fluticasone Propionate	188	75
Metoprolol Succinate	Metoprolol Succinate	178	51
Trazodone Hcl	Trazodone Hcl	178	50
Simvastatin	Simvastatin	176	54
Metformin Hcl Er	Metformin Hcl	175	52
Tamsulosin Hcl	Tamsulosin Hcl	166	56
Alprazolam	Alprazolam	157	30
Potassium Chloride	Potassium Chloride	126	44
Albuterol Sulfate Hfa	Albuterol Sulfate	121	46
Duloxetine Hcl	Duloxetine Hcl	116	32
Eliquis	Apixaban	116	29
Famotidine	Famotidine	105	38
Clopidogrel	Clopidogrel Bisulfate	101	31
Tramadol Hcl	Tramadol Hcl	101	30
Furosemide	Furosemide	99	39
Metoprolol Tartrate	Metoprolol Tartrate	97	26
Mirtazapine	Mirtazapine	91	26
Allopurinol	Allopurinol	89	28
Chlorthalidone	Chlorthalidone	86	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	15
Montelukast Sodium	Montelukast Sodium	82	21
Ozempic	Semaglutide	77	24
Trulicity	Dulaglutide	77	17
Buspirone Hcl	Buspirone Hcl	76	20
Jardiance	Empagliflozin	76	20
Carvedilol	Carvedilol	73	26
Fluoxetine Hcl	Fluoxetine Hcl	72	16
Zolpidem Tartrate	Zolpidem Tartrate	71	18
Ezetimibe	Ezetimibe	68	21
Atenolol	Atenolol	65	19
Cephalexin	Cephalexin	64	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	62	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	16
Glipizide Er	Glipizide	60	13
Celecoxib	Celecoxib	56	19
Finasteride	Finasteride	56	15
Amoxicillin	Amoxicillin	54	44
Escitalopram Oxalate	Escitalopram Oxalate	52	17
Meloxicam	Meloxicam	50	18
Tizanidine Hcl	Tizanidine Hcl	47	15
Alendronate Sodium	Alendronate Sodium	46	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	14
Bupropion Xl	Bupropion Hcl	44	12
Prednisone	Prednisone	44	31
Triamcinolone Acetonide	Triamcinolone Acetonide	44	26
Paroxetine Hcl	Paroxetine Hcl	42	11
Valsartan	Valsartan	42	suppressed
Lorazepam	Lorazepam	41	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	11
Clonazepam	Clonazepam	35	13
Lovastatin	Lovastatin	35	suppressed
Benazepril Hcl	Benazepril Hcl	34	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Rybelsus	Semaglutide	33	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	32	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Ramipril	Ramipril	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	22
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Diazepam	Diazepam	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	20
Temazepam	Temazepam	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Acyclovir	Acyclovir	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Azithromycin	Azithromycin	20	15
Nifedipine Er	Nifedipine	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Klor-Con M10	Potassium Chloride	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Risperidone	Risperidone	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Spironolactone	Spironolactone	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Colchicine	Colchicine	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Naproxen	Naproxen	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Methylprednisolone	Methylprednisolone	15	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Baclofen	Baclofen	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Torsemide	Torsemide	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error